期刊文献+

喉癌与手术切缘组织PCNA和Cdc2表达与局部复发相关性研究 被引量:3

Relationship between expression of PCNA and Cdc2 and local recurrence of tumor in early laryngeal cancer with negative surgical margins
原文传递
导出
摘要 目的研究早期喉癌手术切缘组织学检测癌阴性组织PCNA和Cdc2表达与肿瘤局部复发的关系。方法选取2004-01-01-2010-12-31唐山市协和医院85例早期喉癌患者作为研究对象,采用CO2激光手术治疗并进行回顾性研究。采用免疫组织化学方法(SP)对肿瘤及其切缘组织中PCNA和Cdc2的表达进行检测。所有患者均随访>2年,对其生存及肿瘤局部复发情况进行观察。结果85例喉癌患者中有14例局部复发(复发组),71例未复发(未复发组)。85例患者肿瘤组织中PCNA阳性表达率为72.94%(62/85),Cdc2阳性表达率为70.59%(60/85)。肿瘤组织PCNA的表达与喉癌的分化程度(χ2=0.001,P=0.979)及分期(χ2=0.132,P=0.716)差异无统计学意义;Cdc2的表达与喉癌的分化程度(χ2=1.803,P=0.179)及分期(χ2=0.232,P=0.630)差异无统计学意义。切缘组织中PCNA和Cdc2阳性率分别为32.94%(28/85)和29.41%(25/85)。局部复发率为16.47%(14/85),喉癌复发组切缘组织中PCNA和Cdc2蛋白表达阳性率分别为64.28%(9/14)和26.76%(19/71);未复发组分别为57.14%(8/14)和23.94%(17/71)。经统计学处理,喉癌复发组织PCNA和Cdc2蛋白阳性表达率差异有统计学意义,χ2=7.454,P<0.01;未复发组阴性切缘组织中阳性表达率差异有统计学意义,χ2=6.208,P<0.05。结论早期喉癌阴性手术切缘组织中PCNA和Cdc2的表达是预测术后复发的重要生物学标志,癌切缘组织PCNA和Cdc2蛋白联合检测癌阴性组织对判断早期喉癌术后是否发生局部复发具有一定价值。 OBJECTIVE To explore the relationship between expression of PCNA and Cdc2 in the early laryngeal cancer with negative surgical margins and the local recurrence of tumor. METHODS Totally 86 cases of laryngeal squa- mous cell carcinoma with negative surgical margins were randomly selected from January 1, 2004 to December 31, 2010 in Tangshan Xiehe Hospital. CO2 laser surgery were adopted as treatment and all of the 85 cases were taken into retrospec- tive cohort study. The expression of PCNA and Cdc2 was detected in the tumor tissue and surgical margins. All patients were followed up for more than two years to observe the survival rate and local recurrence. RESULTS The two-year fol- low-up showed that 14 cases of laryngeal squamous cell carcinoma had the local recurrence while 71 cases had not. The expression rates of PCNA and Cdc2 in the 85 early laryngeal cancer tissues were 72.94% (62/85) and 70.59% (60/86) There was no significant difference between expression of PCNA and Cdc2 in tumor tissue and differentiation degree and tumor staging (x^2=0. 001,P=0. 979, x^2=0. 132,P=0. 716, x^2 =1. 803,P=0. 179, 7.2 =0. 232,P=0. 630) ;The posi- tive rates of PCNA and Cdc2 in the surgical margin tissues were 32.94% (28/85), 29.41% (25/85), respectively. Fol- low-up data showed that 14 cases had the local recurrence, accounting for 16.47%. The expression rates of the PCNA and Cdc2 proteins in the recurrence group and non-recurrence group were 64.28% (9/14), 26.76% (19/71) and 57.14% (8/14), 23.94% (17/71), respectively. Statistical analyses showed that the marginal positive rate between the recurrence group and non recurrence group had significant difference (x^2=7. 454,P〈0.01;x^2 = 6. 208,P〈0.05). CONCLUSIONS The expression of PCNA and Cdc2 in surgical margins of early taryngeal cancer is an important biological marker for e- valuation of local recurrence. Combined detection of PCNA and Cdc2 in negative surgical margins of early laryngeal cancer has certain value to determine postoperative local recurrence of tumor.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第21期1701-1705,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 早期喉癌 手术切缘组织 PCNA CDC2 局部复发 回顾性分析 early laryngeal cancer surgical margin tissue PCNA Cdc2 local recurrence retrospective study
  • 相关文献

参考文献15

  • 1Rubinstein M, William B. Armstrong,et al. Transoral laser mi- crosurgery for laryngeal cancer: A primer and review of laser [J].Lasers Med Sci, 2011, 26(1):113-124.
  • 2Bussu F, Ranelletti FO, Gessi M, et al. Immunohistoehemieal ex- pression patterns of the HER4 receptors in normal mucosa and in laryngealsquamous cell carcinomas: antioncogenic significance of the HER4 protein in laryngeal squamous cell carcinoma[J]. La- ryngoscope, 2012,122 (8) : 1724-1733.
  • 3Kulagin RN. Molecular prognostic markers of lymphogenous metas- tasis of squamous cell carcinoma of the larynx: an immuno-histo- chemical study[J]. Vestn Otorinolaringolo, 2011,5(1) :11-14.
  • 4Phinyo M, Visudtiphole V, Roytrakul S, et al. Characterization and expression of cell division cycle 2(Cdc2) mRNA and protein during ovarian development of the giant tiger shrimp Penaeus monodon[J]. Gen Endocrinol, 2013,193 : 103-111.
  • 5Chen B, Duan L, Yin G, et al. miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O[J]. J Chemother, 2013,25 (4) : 229- 238.
  • 6Groehler AL, Lannigan DA. A chromatin-bound kinase, ERK8, protects genomic integrity by inhibiting HDM2-mediated degra- dation of the DNA clamp PCNA[J]. J Cell Biol, 2010,190 (4): 575-586.
  • 7Chang CC, Hung CM, Yang YR, et al. Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/ CDC2 in human ovarian cancer ceils[J]. J Ovarian Res, 2013,6(1):41-47.
  • 8李波,阙祥勇,李意,李新志.cdc2基因在多种人类肿瘤细胞中的表达及意义[J].广东医学,2012,33(14):2035-2037. 被引量:3
  • 9陈新,周健,王元银,何家才,王银龙.舌鳞癌中p34cdc2与cyclin B1的表达及相关研究[J].安徽医科大学学报,2008,43(6):620-623. 被引量:2
  • 10辛丽,邵淑丽.卵巢上皮源性肿瘤Polo样激酶1的表达及其与p34cdc2的相关性[J].中华肿瘤防治杂志,2010,17(15):1203-1205. 被引量:3

二级参考文献64

  • 1阮敏,王元银,陈乔尔,王银龙,何家才,周健.舌鳞癌环氧化酶-2的表达及临床意义[J].安徽医科大学学报,2004,39(5):333-335. 被引量:3
  • 2Hartwell L H, Kastan M B. Cell cycle control and cancer[J]. Science, 1994,266 (5192 ) : 1821 - 8.
  • 3Sherr C J. Cancer cell cycle [ J ]. Science, 1996,274 (5293) : 1672-7.
  • 4Wada S, Yue L, Furuta I, et al. Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma [ J ]. Oral Oncol, 2004, 40(2) :164 -9.
  • 5Hassan K A, El-Naggar A K, Sofia J C et al. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongne[J]. Clin Cancer Res, 2001,7(8) :2458 -62.
  • 6Samuel T, Weber H O, Funk J O. Linking DNA damage to cell cycle checkpoints [ J ]. Cell Cycle. 2002,1 (3) : 162 - 8.
  • 7Hunter T, Pines J. Cyclins and cancer.Ⅱ : Cyclin D and CDK inhibitors come of age[J]. Cell,1994,79(4) :573 -82.
  • 8Sanchez V, McElroy A K, Spector D H. Mechanisms governing maintenance of CDK1/cyclin B1 kinase activity in cells infected with human cytomegalovirus [ J ]. J Virol. 2003, 77 ( 24 ) : 13214 - 24.
  • 9Goodger N M, Gannon J, Hunt T, et al. The localization of p34cdc2 in the cells of normal, hyperplastic, and malignant epithelial and lymphoid tissues of the oral cavity[ J]. J Pathol, 1996, 178(4) :422 -8.
  • 10Yasui W, Yokozaki H, Fujimoto J, et al. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach[J]. J Gas troenterol, 2000, 35(Suppl 12): 111- 115.

共引文献27

同被引文献20

  • 1陶小华,孟群,潘卫利,董玉娥,罗静,程浩.尖锐湿疣患者皮损中SOCS1和PIAS1的表达及意义[J].中华皮肤科杂志,2007,40(5):283-285. 被引量:11
  • 2Ristimaki A, Sivula A, Lundin J, et al. Prognostic significance of elevated cyclooxygenase -2 expression in breast cancer [ J]Cancer Res ,2002,62 (3) :632-635.
  • 3Daikoku T, Terakawa J, Hossain MM,, et al. Mammalian target of rapamycin complex 1 and cyclooxygenase 2 pathways coopera- tively exacerbate endometrial cancer[ J] Am J Pathol,2014, 184 (9) :2390-2402.
  • 4Focht KL, Martin-Harris B, Bonilha HS. Stroboscopic parame-ters reported as voice outcome measures in patients treated forlaryngeal cancer: A systematic review[J], J Med Speech LangPathol,2013,21(3) :715-721.
  • 5Yoshida K,Sasaki R?Nishimura H,et al. Nuclear factor-kappaBexpression as a novel marker of radioresistance in early-stage la-ryngeal cancer[J]. Head Neck,2010,32(5) :646-655.
  • 6Rades D, Huttenlocher S, Seibold ND’et al. Nuclear expressionof p65 (RelA) in patients receiving post-operative radiotherapyfor locally advanced squamous cell carcinoma of the head andneck[J], BMC Cancer,2015,15 : 102 :172-179.
  • 7Rapino F* Abhari BA,Jung M, et al. NIK is required for NF-kappaB-mediated induction of BAG3 upon inhibition of constitu-tive protein degradation pathways[J/CD]. Cell Death Dis,2015,6(2):el692.
  • 8Sato-Tadano A, Suzuki T, Amari M, et al. Hexokinase H in breastcarcinoma : a potent prognostic factor associated with hypoxia-induc-ible factor-lalpha and Ki-67 [J], Cancer Sci* 2013,104 (10) : 1380-1388.
  • 9Tong L, Yuan Y, Wu S. Therapeutic microRNAs targeting theNF-kappa B signaling circuits of cancers [J]. Adv Drug DelivRev,2015,81(3):M5.
  • 10Jiang LZ,Wang P, Deng B,et al. Overexpression of ForkheadBox Ml transcription factor and nuclear factor-kappaB in laryn-geal squamous cell carcinoma : a potential indicator for poorprognosis[J]. Hum Pathol,2011,42(8) : 1185-1193.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部